Massive study aims to unlock secrets of rare genetic disorders

NCT ID NCT04395495

Recruiting now Knowledge-focused Sponsor: Children's Hospital Medical Center, Cincinnati Source: ClinicalTrials.gov ↗

First seen Jan 05, 2026 · Last updated Jun 18, 2026 · Updated 22 times

Summary

This study is collecting blood, tissue, and medical information from up to 1,000 people with RASopathies—a group of genetic conditions that affect development and raise cancer risk. Researchers will store these samples and data in a database for future studies. The goal is to learn more about how these disorders work, not to test a new treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NEUROFIBROMATOSIS 1 are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Cincinnati Children's Hospital Medical Center
RECRUITING

Cincinnati, Ohio, 45229, United States

Contact

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

The condition(s) this trial relates to.

cardiofaciocutaneous syndrome Costello syndrome intellectual developmental disorder 62 intellectual disability, autosomal dominant 5 Legius syndrome macrocephaly-intellectual disability-neurodevelopmental disorder-small thorax syndrome neurofibromatosis type 1 neurofibromatosis-Noonan syndrome Noonan syndrome Noonan syndrome with multiple lentigines RASopathy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CARDIOFACIOCUTANEOUS SYNDROME CARDIOFACIOCUTANEOUS SYNDROME COSTELLO SYNDROME COSTELLO SYNDROME DLG4 GATOR-1 GENE MUTATION LEGIUS SYNDROME LEGIUS SYNDROME MAPK1 GENE MUTATION MAPK1 GENE MUTATION MAPK1 GENE MUTATION MTOR GENE MUTATION NEUROFIBROMATOSIS 1 NOONAN NEUROFIBROMATOSIS SYNDROME NOONAN SYNDROME NOONAN SYNDROME WITH MULTIPLE LENTIGINES RAS MUTATION RAS MUTATION SMITH-KINGSMORE SYNDROME SYNGAP1-RELATED INTELLECTUAL DISABILITY